Program

 

MAIN PROGRAM

Day 1 - Thursday, 17 September 2020

 
 09:00 Opening of the Workshop 
 Session 1: What is New in HIV Prevention and Epidemiology?
 
 09:15Noori,Teymur 2018
2020: Have We Reached the 90-90-90 Targets? 
Teymur Noori - European Centre for Disease Prevention and Control (ECDC), Sweden
 
 09:40State-Of-The-Art Update on Vaccines 
 10:05


PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers?
Milosz Parczewski, MD, PhD - Pomeranian Medical University, Poland

 
 10:30Gender neutral avatar 120x160Harm Reduction Strategies in Drug Users: What Can We Learn?
Tetiana Deshko, PhD - Alliance for Public Health, Ukraine
 
    
 10:55 Coffee break and poster viewing 
    
 Session 2: HIV and Viral Hepatitis in Women: Hot Topics
 
 11:25 Haberl, Annette 2013ART in Women: Which Drugs are Safe and What are the Challenges?
Annette Haberl, MD - HIVCENTER University Hospital Frankfurt, Germany
 
 11:50Gender neutral avatar 120x160
Management of Viral Hepatitis during Pregnancy
Justyna Kowalska, MD - Hospital for Infectious Diseases, Poland
 
  Abstract-Driven Presentations 
 12:15 - 
12:45
4 slots 
    
 13:00Group picture and Lunch  
    
 Session 3: Session organized together with Hepatology Society
 
 14:00HBV 
 14:30HCV 
  Abstract-Driven Presentations 
 15:00 1 slot 
    
 15:15Coffee Break and poster viewing 
    
 Session 4: Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain?
 
 15:45


Pro Standpoint
Jürgen Rockstroh, MD - University of Bonn, Germany

 
 16:00

Con Standpoint
Laura Waters, MD - Central & North West London NHS Trust, UK

 
 16:15Discussion and Audience Voting 
    
 16:30Industry-Sponsored Symposium 
    
  End of Day 1
Welcome Reception and Poster Viewing
 
  Group Dinner
 
    
 

Day 2 - Friday, 18 September 2020

 
    
  Industry-Sponsored Symposium 
  7:00 - 8:00 Early Morning Meet the Expert Session on Clinical Cases 
 Session 5: What is New in the Antiretroviral Treatment Armamentarium?
 
 9:00


Managing Highly Treatment-Experienced Patients: What are the New Drug Options?
Anca Streinu - Cercel, MD, PhD - National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania

 
 9:30Long-Acting Therapies: Which Patients Will Benefit Most? 
  Abstract-Driven Presentations 
 10:00 -
10:20

3 slots

 
    
 10:30Coffee Break and Poster Viewing 
    
  11:00Industry-Sponsored Symposium 
    
 12:00 Lunch 
    
 Session 6: Hot Topics in HIV and Hepatitis
 
 13:00STI Diagnostics in the CEE Region 
 13:30


The Acute HCV Epidemic in MSM: What Have We Learned Thus Far?
Christoph Boesecke, MD - Universitätsklinikum Bonn, Germany

 
 14:00

Gender neutral avatar 120x160
HIV and COVID-19 co-infection: An update
Cristiana Oprea MD, PhD - Carol Davila University of Medicine and Pharmacy, Romania

 
    
 14:30 End of meeting